In this context, our analysis did reveal that a large majority of CD82 negative tumors (61% of 30 patients) were associated with HPV16, thus further indicating that the lack of CD82 expression may contribute to a poor prognosis in vulvar carcinomas. Here, CD82 is linked to vulvar carcinoma.